review on glp-1 agonists and psychiatric effects Glucagon-like peptide-1 medicines in neurological disorders: Cell Reports Medicine GLP-1 receptor agonists show promise

But injections require more commitment

J Dermatolog Treat 31:8490

Importantly, underuse of therapies directed at heart and kidney protection was noted in individuals with type 1 diabetes compared with those with type 2 diabetes in the Scandinavian cohort [7]

List price per month: $987.19* Victoza (liraglutide) Form: Injectable GLP-1 Uses: FDA-approved to improve glycemic control in adults and children over 10 with type 2 diabetes and reducing the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular diseases

As such, removal of the health equity adjustment would not impact an ACO's performance under MIPS

Food Science & Nutrition, 8 (12), 6691